Reuters Business(@ReutersBiz):Nestle is seeking to turn the rise of GLP-1 weight-loss drugs from a threat into a business opportunity, using artificial intelligence and nutritional science to develop products aimed at millions of consumers taking medicines such as Ozempic and Wegovy

Reuters Business

@ReutersBiz

The latest business and financial news from around the 🌍 with insights from @breakingviews. Our new daily podcast is here:

参加 June 2008

237 フォロー中 3.4M ファン

Reuters Business@ReutersBiz

2026.08.17 06:31

Nestle is seeking to turn the rise of GLP-1 weight-loss drugs from a threat into a business opportunity, using artificial intelligence and nutritional science to develop products aimed at millions of consumers taking medicines such as Ozempic and Wegovy